Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Yesterday, BITB had a net outflow of 25.7 million US dollars, and ETHE had a net outflow of 20.3 million US dollars

Yesterday, BITB had a net outflow of 25.7 million US dollars, and ETHE had a net outflow of 20.3 million US dollars

Bitget2024/08/19 23:29

According to Farside Investors, as of the time of publication, the data for US spot Bitcoin ETF and spot Ethereum ETF (August 19) is as follows:

Spot Bitcoin ETF: BITB had a net outflow of $25.7 million; GBTC, ARKB, BTC, EZBC had no funds inflow or outflow.

Spot Ethereum ETF: ETHE had a net outflow of $20.3 million; ETH had a net inflow of $4.9 million; ETHW had a net inflow of $1.9 million; EZET, CETH had no funds inflow or outflow.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. Stocks Movement | Storage Chip Concept Stocks Rise Across the Board, SNDK (SanDisk) Up 6%

On Monday, storage chip concept stocks generally rose, with SanDisk (SNDK.US) up by 6%.

智通财经2026/08/17 13:51
U.S. Stocks Movement | Storage Chip Concept Stocks Rise Across the Board, SNDK (SanDisk) Up 6%

AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds

On August 17, AstraZeneca (AZN.US) and Daiichi Sankyo jointly announced that the Phase III DESTINY-Lung04 study of Enhertu (trastuzumab deruxtecan) as a monotherapy for first-line treatment of non-small cell lung cancer (NSCLC) has achieved highly positive results.

智通财经2026/08/17 12:56
AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds